Skip to main content
eBioMedicine logoLink to eBioMedicine
. 2024 Apr 16;103:105126. doi: 10.1016/j.ebiom.2024.105126

Impact of ambient air pollution on colorectal cancer risk and survival: insights from a prospective cohort and epigenetic Mendelian randomization study

Fangyuan Jiang a, Jianhui Zhao a, Jing Sun a, Wenxi Chen a, Yuyuan Zhao a, Siyun Zhou a, Shuai Yuan b, Maria Timofeeva c, Philip J Law d, Susanna C Larsson b,e, Dong Chen f, Richard S Houlston d, Malcolm G Dunlop g, Evropi Theodoratou g,h, Xue Li a,
PMCID: PMC11035091  PMID: 38631091

Summary

Background

This study investigates the associations between air pollution and colorectal cancer (CRC) risk and survival from an epigenomic perspective.

Methods

Using a newly developed Air Pollutants Exposure Score (APES), we utilized a prospective cohort study (UK Biobank) to investigate the associations of individual and combined air pollution exposures with CRC incidence and survival, followed by an up-to-date systematic review with meta-analysis to verify the associations. In epigenetic two-sample Mendelian randomization analyses, we examine the associations between genetically predicted DNA methylation related to air pollution and CRC risk. Further genetic colocalization and gene–environment interaction analyses provided different insights to disentangle pathogenic effects of air pollution via epigenetic modification.

Findings

During a median 12.97-year follow-up, 5767 incident CRC cases among 428,632 participants free of baseline CRC and 533 deaths in 2401 patients with CRC were documented in the UK Biobank. A higher APES score was associated with an increased CRC risk (HR, 1.03, 95% CI = 1.01–1.06; P = 0.016) and poorer survival (HR, 1.13, 95% CI = 1.03–1.23; P = 0.010), particularly among participants with insufficient physical activity and ever smokers (Pinteraction > 0.05). A subsequent meta-analysis of seven observational studies, including UK Biobank data, corroborated the association between PM2.5 exposure (per 10 μg/m3 increment) and elevated CRC risk (RR,1.42, 95% CI = 1.12–1.79; P = 0.004; I2 = 90.8%). Genetically predicted methylation at PM2.5-related CpG site cg13835894 near TMBIM1/PNKD and cg16235962 near CXCR5, and NO2-related cg16947394 near TMEM110 were associated with an increased CRC risk. Gene-environment interaction analysis confirmed the epigenetic modification of aforementioned CpG sites with CRC risk and survival.

Interpretation

Our study suggests the association between air pollution and CRC incidence and survival, underscoring the possible modifying roles of epigenomic factors. Methylation may partly mediate pathogenic effects of air pollution on CRC, with annotation to epigenetic alterations in protein-coding genes TMBIM1/PNKD, CXCR5 and TMEM110.

Funding

Xue Li is supported by the Natural Science Fund for Distinguished Young Scholars of Zhejiang Province (LR22H260001), the National Nature Science Foundation of China (No. 82204019) and Healthy Zhejiang One Million People Cohort (K-20230085). ET is supported by a Cancer Research UK Career Development Fellowship (C31250/A22804). MGD is supported by the MRC Human Genetics Unit Centre Grant (U127527198).

Keywords: Air pollution, Colorectal cancer, Incidence, Survival, Mendelian, Randomization, DNA methylation


Research in context.

Evidence before this study

Sporadic and inconsistent epidemiological evidence has linked air pollution to the development of colorectal cancer (CRC). The epigenome is emerging as a vital link between environmental exposure, alterations in gene expression, and the onset of CRC. Whether and how air pollution plays a role in the development of CRC was inconclusive and needed to be clarified.

Added value of this study

We initially introduced the Air Pollutants Exposure Score (APES) and unveiled that a higher APES score was associated with both an increased CRC risk and poorer survival, specifically among participants with insufficient physical activity and ever smokers. The epigenetic MR analyses disclosed that genetically predicted methylation at two PM2.5- and one NO2-related CpG site appeared to elevate CRC risk. And the impact of epigenetic modifications on CRC risk and survival in protein-coding genes TMBIM1/PNKD, CXCR5, and TMEM110 were additionally validated.

Implications of all the available evidence

Leveraging the integrative observational, genetic, and methylation evidence, our study underscored the crucial importance of assessing combined air pollution effects and other modifiable environmental factors for both primary and secondary CRC prevention. It also shed light on the profound impact of epigenetic alterations in the complex pathogenesis of CRC, suggesting that methylation may serve as partial mediators in the deleterious effects of air pollution on CRC.

Introduction

Colorectal cancer (CRC) is one of the most common cancers as well as a leading cause of cancer-related death worldwide.1 Its etiology encompasses a spectrum of lifestyle and environmental factors.2,3 As the most significant environmental health threat,4 ambient air pollution has been associated with cancer development through affecting the inflammatory system.5,6 Sporadic and inconsistent epidemiological evidence has linked air pollution to the development of CRC.7, 8, 9, 10 A recent meta-analysis indicated significant associations between particulate matter (PM) and an evaluated risk of gastrointestinal cancer incidence and mortality, notably liver cancer and CRC.11 The specific role of PM in CRC incidence remains inconclusive,7,8 with the effects of other pollutants (such as nitrogen oxides) and their combined impacts being largely unexplored. Similarly, while research has recognized detrimental effects of long-term air pollution exposure on the mortality risk among patients diagnosed with cancer,12,13 insights into overall survival in patients with CRC are lacking.

Although air pollution has been shown to affect the immune system and is associated with chronic systemic inflammation, oxidative stress, and DNA damage during cancer development,5,14 the underlying mechanisms remain inadequately derdetermined. Emerging epigenome-wide association studies (EWAS) suggested that air pollution exposure altered epigenetic marks, specifically DNA methylation (DNAm),15, 16, 17 which might in turn influence inflammation, disease development, and exacerbation risk.18 Meanwhile, the aberrant DNAm patterns, characterized by 5-methylcytosine formation in cytosine-phosphate-guanine (CpG) dinucleotides, have been identified as a crucial epigenetic mechanism in CRC carcinogenesis by hindering the combination of the transcription complex and DNA, resulting in unprogrammed alterations in downstream gene expression.19,20 However, how air pollution modifies DNAm and subsequently contributes to the pathological effects on CRC is unknown.

Mendelian randomization (MR) analysis is an effective tool for causal inference by utilizing genetic variants as proxies for an exposure (e.g., air pollution-related DNAm), which thus minimizes confounding or reverse causality.21 In our study, we examined the associations of individual and combined ambient air pollution exposures (particulate matters including PM10 and PM2.5, and nitrogen oxides including NOx and NO2) with CRC risk and overall survival. We further explored the potential pathological effect related to air pollution induced DNAm and the gene–environment interaction effects.

Methods

Study design

Fig. 1 shows the study design overview. We initially investigated the associations between air pollution and both CRC incidence and survival among patients with CRC in the UK Biobank cohort. We subsequently conducted an up-to-date systematic review with meta-analysis investigating the association between PM exposure and CRC outcomes (incidence or CRC specific-mortality) to validate the epidemiologic associations. To elucidate the underlying pathogenic mechanism, two-sample MR analyses were utilized, incorporating genetic instruments for blood DNAm related to air pollution and summary-level Genome-Wide Association Study (GWAS) data for CRC incidence. In addition, genetic colocalization and gene–environment interaction analyses were performed to further shed light on the potential carcinogenic or prognostic effects of air pollution on CRC.

Fig. 1.

Fig. 1

Schematic diagram of the study design.

Prospective cohort study and updated meta-analysis

Study population

The UK Biobank is a large-scale cohort study (∼500,000 participants aged 40–69 at enrollment) collecting genotypic and phenotypic health-related information. Participants with other cancer diagnoses at baseline (n = 34,969) and those lacking data on air pollution (n = 38,889) were removed from the CRC incidence analysis, resulting in a cohort of 428,632 participants for this analysis (Supplemental Figure S1). The evaluation of all-cause mortality among patients with CRC was confined to participants with prior CRC diagnosis at recruitment. After excluding those with missing air pollution data (n = 229), 2401 patients with CRC were eligible for analysis of which 533 died (Supplemental Figure S1). The UK Biobank received the ethical approval from the North West Multicenter Research Ethics Committee (REC reference: 21/NW/0157) and all participants signed consent.

Assessment of air pollutants

We treated four air pollutants (NOx, NO2, PM10, and PM2.5) as primary exposures based on data availability in the UK Biobank and corresponding criteria set by the World Health Organization (2021) and European Commission (2022). The annual average concentrations were modeled by Land Use Regression (LUR) techniques using the predictor variables obtained from the Geographic Information System and the linkage to participants’ residential addresses at the baseline visit.22 The LUR model demonstrated high performance for PM2.5, PM10, NO2, and NOx with a cross-validation R2 of 77%, 88%, 87%, and 88%, respectively. For PM2.5 and NOx, air pollution estimates were only available for the year 2010. NO2 (2005-7 and 2010) and PM10 (2007 and 2010) had data for multiple years; hence, we employed the mean values in the analysis. To quantify the combined exposure to various air pollutants and its impact on CRC, a weighted air pollutants exposure score (APES) was created based on the β coefficient of each air pollutant in multivariable Cox regression: APES = (βPM2.5∗PM2.5 + βPM10∗PM10 + βNO2∗NO2 + βNOx∗NOx) ∗ (4/sum of the β coefficients)23 (details in Supplementary Table S1).

Ascertainment of incidence and deaths of CRC

The clinical outcomes of interest were incident CRC and all-cause mortality among CRC participants. CRC diagnosis was confirmed via linkage to national cancer registries in England, Wales, and Scotland (follow-up through 20 February 2022) and inpatient medical records (follow-up through 31 March 2021). The International Classification of Diseases codes (ICD-9: 153, 154.0, and 154.1; ICD-10: C18-C20) were used to identify prevalent or incident CRC either as the first or second diagnosis. Mortality data were extracted from the death registry (follow-up through 31 March 2021). Information on covariates including age, sex, education attainment, ethnicity, family history of bowel cancer, BMI, alcohol intake, and smoking was assessed during the baseline survey. Gender data from UK Biobank was compiled from registry records and self-reporting.24

Statistical analysis

A multivariable Cox proportional hazards regression model was employed to estimate adjusted hazard ratios (HRs) and 95% confidence intervals (95% CIs) for associations between air pollution exposure and CRC risk and survival. Two levels of statistical adjustments were made: model 1 adjusted for age at recruitment and sex, and model 2 further adjusted for education, Townsend deprivation index (TDI), ethnicity, family history of CRC, BMI, alcohol intake, physical activity and smoking status. Follow-up time was calculated from recruitment until the first recording of the corresponding outcomes (incident CRC diagnosis or all-cause death in patients with CRC), death, date of loss, or end of follow-up, whichever occurred first. The proportional hazards assumption was examined using Schoenfeld residuals and found to be satisfied. The Kaplan–Meier survival analysis was conducted to evaluate the impact of air pollution exposure levels on CRC risk and survival, utilizing the “survminer” R package. Subgroup analyses stratified by sex, smoking status, physical activity and autonomic sites were further conducted to explore potential interactive factors based on prior knowledge. Furthermore, we conducted a sensitivity analysis specifically incorporating patients diagnosed with CRC within 5 years preceding recruitment to mitigate the potential impact of survivorship bias. We also performed a sensitivity analysis after excluding participants with a reported family history of CRC to minimize the potential confounding of familial correlations. The Cox regressions were conducted using the “survival” R package. Wald tests based on Cox proportional hazards models were employed, with a P-value of less than 0.05 as statistically significant.

Updated meta-analysis of observational studies

The meta-analysis by Pritchett N et al.11 reviewed the evidence on outdoor air pollution (mainly in particulate matter) and CRC risk, demonstrated as clinically confirmed CRC diagnosis or CRC-related mortality among the general population. However, this review only included original research with cohort or case–control study design between 1980 and September 2021.11 We updated this systematic review to include studies up to January 2023, employing the same methods to study the association between air pollution and CRC endpoints (incidence or CRC-specific mortality). We used PubMed, EMBASE, Cochrane Library, Scopus, and Web of Science for an updated literature search, using keyword describing air pollution exposure (e.g., “outdoor air pollution”, “particulate matter”) and CRC. We employed inverse variance weighted random-effects model to calculate the pooled relative risks (RR) and 95% CIs. Heterogeneity among the studies was quantified using I2 test. Meta-analyses were performed with the “metafor” package in R 4.2.0. Details of the search strategies and eligibility criteria were available in the Supplementary Methods.11

Two-sample epigenetic Mendelian randomization

mQTL for air pollution-related DNA methylation

We sourced blood DNAm related to PM2.5, PM10 and NO2 exposure from three independent EWAS15, 16, 17 consisting of 2956, 365 and 2410 European participants, respectively. DNAm was measured by the Illumina Infinium HumanMethylation450 (HM450) BeadChip array, and the associations between air pollutants and blood DNAm were adjusted for age, sex, BMI, smoking status, alcohol intake, batch effects, and white blood cell types where applicable.15, 16, 17 A total of 1829, 286 and 4980 CpG sites were associated with PM2.5, PM10 and NO2 exposure, which survived the FDR threshold of P < 0.05 at epigenome-wide significance level (Supplementary Table S2).

We then identified CpG site-associated methylation quantitative trait loci (mQTLs) from the Genetics of DNA Methylation Consortium (GoDMC) database, which encompasses genetic and methylation data from over 30,000 individuals.25 These mQTLs, serving as genetic proxies for DNA methylation influenced by air pollution, were selected based on the following criteria. We focused on significant cis-mQTLs (P < 1 × 10−8), located within 1 MB proximity to their respective CpG sites, and exhibiting low linkage disequilibrium (r2 < 0.01). F-statistics were also calculated to measure the strength of instruments (F-statistic  <10 was considered as weak instrument). When evaluating the causal effect of genetically predicted DNA methylation at air pollution related CpG sites on CRC, each air pollution-related CpG site was treated as an independent exposure, and its proxy mQTLs in the GoDMC database were used as genetic instruments. These approaches allowed us to effectively proxy the methylation levels of each CpG site associated with exposures to PM2.5, PM10, and NO2.26

GWAS summary-level data of CRC

GWAS summary statistics for CRC were derived from 12 previously reported GWASs, comprising 20,049 cases and 22,661 controls of European ancestry from the following studies: CCRR1, CCFR2, COIN, CORSA, Croatia, DACHS, FIN, NSCCG OncoArray, SCOT, UK1, VQ58, and Scottish case–control series.27 After standard quality control procedures, a total of 16,871 cases and 26,328 controls were included in the meta-GWAS analysis.27

Two-sample MR

We conducted two-sample MR analysis to elucidate the underlying biology by exploring the causal effects of air pollution-related DNAm on the risk of CRC. For the CpG site with only one mQTL, the Wald ratio was used as the primary analysis.28 The false discovery rate (FDR) with the Benjamini-Hochberg method was applied to account for multiple testing, and the association with an FDR-adjusted P-value <0.05 was considered statistically significant. The heterogeneity of SNPs' estimates and the pleiotropy of the association was examined by Cochran's Q statistics or MR-Egger intercept test, respectively. Additionally, several sensitivity analyses such as weighted median were conducted to test the consistency of the results.

Colocalization of mQTLs and CRC GWAS signals

For CpG sites convincingly associated with the risk of CRC (FDR <0.05), we conducted colocalization analyses to examine whether susceptibility to CRC was driven by the same variants influencing methylation at the CpG sites. The mQTL proxies for methylation at each CpG site and GWAS data for CRC were identical to those used in the MR analysis. Observation of 80% or higher posterior probability of association for both summary effect of the CpG site and single effect of a mQTL were considered as evidence of colocalization. The colocalization analysis was performed using the “coloc” R package.29

Prospective mQTL-air pollution interaction analyses in UK Biobank

We performed prospective mQTL-air pollution interaction analyses to test whether the epigenetic alterations in mapped gene might modify the effects of air pollution on CRC risk and survival. We retrieved the genotyping data of their mQTLs in the UK Biobank to test whether the associations of air pollution with CRC risk and overall survival, is modified by the genetic polymorphisms of CpG-mapped genes. The interaction analyses were performed using the “CGEN” R package, adjusting for age at recruitment, sex, education, TDI, ethnicity, family history of CRC, BMI, alcohol intake, physical activity, smoking and the first 10 genetic principal components. For the mQTLs significantly interacted with a specific air pollutant or APES, we further conducted stratification analyses to assess the dose–response effects based on their genotypes. All statistical tests were two-tailed and performed using R software 4.2.0. P-value <0.05 was considered statistically significant.

Role of funders

The funding sources had no role in the design of this study and did not have any role in data collection, data analyses, interpretation, writing of report, or decision to submit results.

Results

Baseline characteristics of prospective cohort study

After a median of 12.97 years of follow-up, the CRC incidence analysis included 415,887 participants, among which 5767 CRC cases were newly diagnosed. Furthermore, 533 cases of all-cause death were recorded among 2401 patients with CRC. Supplementary Tables S3 and S4 summarized the distribution of baseline characteristics according to the status of incidence and survival.

Air pollution and risk of CRC incidence

Table 1 presented the results of minimally and fully adjusted HRs for the associations between air pollutants exposure and risk of CRC incidence. No significant associations were observed between individual air pollutant and CRC risk. However, when examining joint exposure to various air pollutants and their effect on CRC incidence, we found a significant association of APES with increased CRC risk in the fully adjusted model (HR = 1.03, 95% CI = 1.01–1.06). The results remained consistent after excluding participants with a reported family history of CRC (Supplementary Table S5). Adjusted Kaplan–Meier survival analysis (Supplementary Figure S2) showed suggestive differences in CRC incidence across diverse levels of PM10 (log-rank P = 0.007) and NOx (log-rank P = 0.027).

Table 1.

Associations between individual and combined exposure to air pollution and risk of CRC incidence in UK Biobank.

Pollution Cases Model 1
Model 2
HR (95% CI) P value HR (95% CI) P value
PM2.5(μg/m3)
 Q1 1499 1.00 (ref) 1.00 (ref)
 Q2 1436 0.97 (0.90, 1.04) 0.386 0.98 (0.91, 1.05) 0.565
 Q3 1469 1.04 (0.97, 1.12) 0.300 1.05 (0.98, 1.13) 0.192
 Q4 1363 1.00 (0.93, 1.08) 0.939 1.01 (0.94, 1.09) 0.776
 P for trend 0.595 0.483
 Per 5-μg/m3∗day 1.08 (0.95, 1.22) 0.239 1.09 (0.95, 1.24) 0.211
PM10(μg/m3)
 Q1 1505 1.00 (ref) 1.00 (ref)
 Q2 1469 1.00 (0.93, 1.07) 0.894 1.00 (0.93, 1.08) 0.997
 Q3 1473 1.03 (0.96, 1.10) 0.463 1.03 (0.96, 1.11) 0.376
 Q4 1320 0.97 (0.90, 1.05) 0.480 1.00 (0.92, 1.08) 0.920
 P for trend 0.616 0.915
 Per 5-μg/m3∗day 0.98 (0.91, 1.04) 0.478 1.00 (0.93, 1.08) 0.933
NO2(μg/m3)
 Q1 1494 1.00 (ref) 1.00 (ref)
 Q2 1481 1.00 (0.93, 1.08) 0.961 1.01 (0.94, 1.08) 0.806
 Q3 1439 1.01 (0.94, 1.08) 0.882 1.01 (0.94, 1.09) 0.696
 Q4 1353 1.00 (0.93, 1.08) 0.900 1.03 (0.95, 1.12) 0.451
 P for trend 0.885 0.447
 Per 5 μg/m3∗day 1.00 (0.99, 1.01) 0.974 1.01 (0.99, 1.02) 0.385
NOx(μg/m3)
 Q1 1534 1.00 (ref) 1.00 (ref)
 Q2 1453 0.97 (0.90, 1.04) 0.352 0.97 (0.9, 1.04) 0.442
 Q3 1386 0.95 (0.89, 1.03) 0.197 0.96 (0.9, 1.04) 0.339
 Q4 1394 1.01 (0.94, 1.09) 0.785 1.02 (0.95, 1.11) 0.572
 P for trend 0.833 0.620
 Per 5-μg/m3∗day 1.00 (0.99, 1.01) 0.730 1.00 (0.99, 1.01) 0.489
Combined air pollution exposure score (per SD increment) 5767 1.04 (1.01, 1.07) 0.008 1.03 (1.01, 1.06) 0.016

Model 1 adjusted for age at recruitment and sex.

Model 2 adjusted for age at recruitment, sex, education, Townsend deprivation index (TDI), ethnicity, family history of CRC, BMI, alcohol intake, physical activity and smoking.

Further stratification analyses by sex, smoking behaviors and physical activity revealed significant associations between APES and CRC risk in men (HR = 1.01, 95% CI = 1.00–1.01), ever or current smokers (HR = 1.05, 95% CI = 1.01–1.08), and in those with insufficient physical activity (HR = 1.05, 95% CI = 1.01–1.08) (Pinteraction > 0.05, details in Supplementary Tables S6–S9). Besides, the adverse effect of APES was significant for colon cancer risk (HR = 1.04, 95% CI = 1.00–1.08), but not for rectal cancer risk.

Air pollution and risk of all-cause mortality in CRC

As shown in fully adjusted models from Table 2, compared to those exposed to the lowest quartile of air pollutants, exposure to the highest quartile of air pollutants was generally associated with an increased risk of all-cause mortality among CRC survivors (HR = 1.43, 95% CI = 1.10–1.87, Ptrend = 0.011 for PM2.5; HR = 1.52, 95% CI = 1.16–2.00, Ptrend = 0.005 for NO2, HR = 1.43, 95% CI = 1.10–1.86, Ptrend = 0.008 for NOx), although not all risk estimates were statistically significant. Per 5 μg/m3 increment in PM10, the risk of all-cause mortality was 28% higher (HR = 1.28, 95% CI = 1.02–1.62) among individuals with CRC. Moreover, the joint exposure to various air pollutants was associated with an elevated risk of mortality in CRC survivors (HR = 1.13, 95% CI = 1.03–1.23). Similar results were found by the adjusted Kaplan–Meier curves in Supplementary Figure S3. These analyses indicated that increased exposure to specific air pollutants, particularly within the higher quartiles, was associated with decreased survival probability in patients with CRC [(log-rank P = 0.004), NO2 (log-rank P = 0.001), NOx (log-rank P = 0.006), and the APES (log-rank P = 0.008)]. The results remained consistent both for patients diagnosed with CRC within the five-year period prior to their recruitment (Supplementary Table S10), and after excluding CRC cases with a reported family history of CRC (Supplementary Table S11).

Table 2.

Associations between individual and combined exposure to air pollution and risk of all-cause mortality among CRC survivors in UK Biobank.

Pollution Cases Model 1
Model 2
HR (95% CI) P value HR (95% CI) P value
PM2.5(μg/m3)
 Q1 104 1.00 (ref) 1.00 (ref)
 Q2 140 1.40 (1.08, 1.80) 0.010 1.34 (1.04, 1.73) 0.024
 Q3 136 1.42 (1.10, 1.84) 0.007 1.35 (1.04, 1.76) 0.023
 Q4 153 1.56 (1.21, 2.00) 0.001 1.43 (1.10, 1.87) 0.008
 P for trend 0.001 0.011
 Per 5-μg/m3∗day 1.77 (1.23, 2.55) 0.002 1.54 (1.04, 2.29) 0.031
PM10(μg/m3)
 Q1 124 1.00 (ref) 1.00 (ref)
 Q2 129 1.05 (0.82, 1.34) 0.712 1.02 (0.79, 1.3) 0.903
 Q3 134 1.10 (0.86, 1.41) 0.427 1.04 (0.81, 1.33) 0.758
 Q4 146 1.27 (1.00, 1.61) 0.051 1.19 (0.93, 1.53) 0.172
 P for trend 0.042 0.156
 Per 5-μg/m3∗day 1.34 (1.08, 1.67) 0.008 1.28 (1.02, 1.62) 0.037
NO2(μg/m3)
 Q1 99 1.00 (ref) 1.00 (ref)
 Q2 139 1.50 (1.16, 1.94) 0.002 1.45 (1.12, 1.88) 0.005
 Q3 149 1.61 (1.25, 2.08) 0.000 1.54 (1.19, 2.00) 0.001
 Q4 146 1.62 (1.25, 2.09) 0.000 1.52 (1.16, 2.00) 0.003
 P for trend 0.000 0.005
 Per 5 μg/m3∗day 1.07 (1.03, 1.12) 0.002 1.06 (1.01, 1.12) 0.016
NOx(μg/m3)
 Q1 106 1.00 (ref) 1.00 (ref)
 Q2 131 1.28 (0.99, 1.66) 0.056 1.25 (0.97, 1.62) 0.089
 Q3 142 1.42 (1.11, 1.83) 0.006 1.35 (1.04, 1.75) 0.023
 Q4 154 1.53 (1.19, 1.96) 0.001 1.43 (1.10, 1.86) 0.008
 P for trend 0.001 0.008
 Per 5-μg/m3∗day 1.04 (1.01, 1.07) 0.003 1.03 (1.00, 1.06) 0.027
Combined air pollution exposure score (per SD increment) 533 1.14 (1.06, 1.24) 0.001 1.13 (1.03, 1.23) 0.011

Model 1 adjusted for age at recruitment and sex.

Model 2 adjusted for age at recruitment, sex, education, TDI, ethnicity, family history of CRC, BMI, alcohol intake, physical activity and smoking.

When stratified by sex, smoking behaviours, physical activity and tumour subsite (Supplementary Tables S12–S15), the associations with PM2.5, NO2, NOx and APES were statistically significant in men, individuals with insufficient physical activity, and survivors of colon cancer, and the associations with oxynitride and APES remained stable in current or ever smokers.

Updated meta-analysis

Two studies published between September 2021 and January 2023 were included in the updated meta-analysis following full-text screening. More details regarding the process of screening are shown in Supplementary Figure S4. These two studies, conducted in South America and Asia, both reported on the association between PM and risk of CRC-specific mortality among general population. Along with four earlier studies, all included studies were retrospective or prospective cohort analyses estimating associations with PM2.5, hence we only summarized PM2.5 associations (Details of included study were shown in Supplementary Table S16).

Fig. 2 presented the pooled HR estimates per 10 μg/m3 increment in PM2.5 (RR = 1.47, 95% CI = 1.12–1.92; I2 = 92.3%) and CRC risk, including four previous studies incorporated in the research by Pritchett N et al. When our current results based on UK Biobank data were included, the association between per 10 μg/m3 increase in PM2.5 and the risk of CRC remained stable (RR = 1.42, 95% CI = 1.12–1.79; I2 = 90.8%) (Fig. 2). Since outdoor air pollution varied significantly regionally in both overall burden and its constituency, the considerable heterogeneity observed might be largely attributable to geographic and ancestry heterogeneity in included studies (i.e., United States, South America, Europe, and China) of our meta-analyses.

Fig. 2.

Fig. 2

Meta-analysis of included epidemiologic studies. Reported effect estimates (95% CI) from individual studies and overall pooled estimate (including the P value) from random-effects (RE) model for PM2.5 exposure (10 μg/m3 increase) and CRC.

Causal effect of air pollution-related DNAm on CRC risk

Initially, 1829, 286 and 4980 CpG sites were identified to be associated with PM2.5, PM10 and NO2 exposure from studies with participants of European ancestry15, 16, 17 (Supplementary Table S2). After applying rigorous selection criteria to ensure the robustness of our genetic instruments, we found 580 CpG sites associated with PM2.5 exposure and their 1022 corresponding mQTLs, 49 CpG sites for PM10 exposure and their 123 corresponding mQTLs, and 3006 CpG sites for NO2 exposure and their 10,676 corresponding mQTLs (Supplementary Tables S17–S19). Table 3 presented the MR estimates of genetically predicted blood DNAm at each CpG site on CRC incidence risk. Genetically predicted methylation at PM2.5-related CpG site cg13835894 [TMBIM1/PNKD] and cg16235962 [CXCR5] were associated with elevated CRC risk, with MR estimates being 1.19 (95% CI = 1.12–1.27) and 1.54 (95% CI = 1.27–1.88), respectively. For NO2, the Wald ratio approach suggested that genetically predicted methylation at CpG site cg16947394 [TMEM110] was linked to increased risk of CRC (OR = 1.57, 95% CI = 1.30–1.89). No apparent heterogeneity was detected for PM2.5-related cg13835894 (Cochrane's Q value = 0.012).

Table 3.

Two-sample Mendelian Randomization estimates of air pollution-related methylation on CRC risk.

Exposure CpG site CpG.Chr CpG.Pos Nearest gene Method SNP OR (95% CI) P value FDR
PM2.5 cg13835894 2 219,148,914 TMBIM1/PNKD IVW rs1870123, rs876961 1.19 (1.12, 1.27) 5.04E-09 4.43E-06
cg16235962 11 118,754,507 CXCR5 Wald ratio rs497916 1.54 (1.27, 1.88) 1.15E-05 0.005
NO2 cg16947394 3 52,930,628 TMEM110 Wald ratio rs11708390 1.57 (1.30, 1.89) 1.88E-06 0.004

Chr, chromosome; Pos, position; OR, odds ratio, CRC risk per SD change in DNA methylation at air pollution related CpG sites in blood; 95% CI, 95% confidence interval; IVW, inverse variance weighted.

Among the three CpG sites significantly associated with CRC risk, methylation at cg16235962, mapped to gene CXCR5, had a 99.7% posterior probability of sharing a causal variant (rs497916) with CRC GWAS signals (Supplementary Figure S5). To investigate whether the mQTLs of three air pollution-related CpG sites would influence the expression of their mapped gene in colon tissue, we queried the GTEx Portal and found that the mQTL rs1870123 of cg13835894 is an eQTL of the TMBIM1 gene (m-value = 1.00) (Supplementary Figures S6–S8).

Prospective mQTL-air pollution interaction effects on CRC risk and survival

Table 4 displayed the prospective mQTL-air pollution interaction effect estimates on CRC risk and survival. Three mQTLs had evidence for interaction with APES on CRC risk or survival, while only rs876961 of cg13835894 [TMBIM1/PNKD] significantly interacted with PM2.5 exposure on CRC survival.

Table 4.

Gene-air pollution interaction estimates for CRC risk and survival in the UK Biobank.

Variables Risk of CRC incidence
Risk of all-cause mortality among CRC survivors
Model 1
Model 2
Model 1
Model 2
HR (95% CI) P value HR (95% CI) P value HR (95% CI) P value HR (95% CI) P value
mQTLs of air pollution related methylation
 rs1870123 1.07 (1.03, 1.11) 0.001 1.07 (1.02, 1.11) 0.002 1.09 (0.94, 1.26) 0.278 1.08 (0.93, 1.26) 0.309
 rs876961 1.02 (0.98, 1.06) 0.338 1.02 (0.98, 1.06) 0.357 0.98 (0.85, 1.13) 0.811 1.00 (0.86, 1.15) 0.965
 rs497916 1.00 (0.96, 1.05) 0.839 1.01 (0.97, 1.06) 0.565 1.19 (1.02, 1.40) 0.032 1.20 (1.02, 1.42) 0.024
 rs11708390 1.03 (0.98, 1.09) 0.252 1.03 (0.97, 1.09) 0.332 0.84 (0.68, 1.03) 0.094 0.82 (0.66, 1.01) 0.057
Gene-individual air pollutant interaction effect
 rs1870123 × PM2.5 (5-μg/m3∗day) 1.11 (0.93, 1.32) 0.244 1.16 (0.95, 1.40) 0.138 1.49 (1.09, 2.02) 0.011 1.35 (0.98, 1.88) 0.067
 rs876961 × PM2.5 (5-μg/m3∗day) 1.13 (0.89, 1.42) 0.307 1.17 (0.91, 1.51) 0.208 1.86 (1.21, 2.85) 0.005 1.72 (1.10, 2.69) 0.018
 rs497916 × PM2.5 (5-μg/m3∗day) 1.18 (0.87, 1.59) 0.286 1.14 (0.83, 1.57) 0.422 1.45 (1.08, 1.94) 0.013 1.32 (0.97, 1.80) 0.079
 rs11708390 × NO2 (5-μg/m3∗day) 1.00 (0.99, 1.02) 0.774 1.00 (0.98, 1.02) 0.943 1.04 (1.01, 1.07) 0.015 1.03 (1.00, 1.07) 0.062
Gene-APES interaction effect
 rs1870123 × APES (per SD) 1.03 (1.01, 1.05) 0.005 1.03 (1.01, 1.05) 0.008 1.09 (1.02, 1.17) 0.010 1.08 (1.00, 1.16) 0.043
 rs876961 × APES (per SD) 1.02 (0.99, 1.05) 0.129 1.02 (0.99, 1.05) 0.169 1.10 (1.00, 1.20) 0.047 1.08 (0.98, 1.19) 0.116
 rs497916 × APES (per SD) 1.05 (1.01, 1.09) 0.006 1.05 (1.01, 1.09) 0.006 1.08 (1.01, 1.15) 0.022 1.06 (0.99, 1.14) 0.092
 rs11708390 × APES (per SD) 1.02 (1.00, 1.03) 0.024 1.02 (1.00, 1.04) 0.024 1.08 (1.02, 1.14) 0.005 1.07 (1.01, 1.14) 0.029

Model 1 adjusted for age at recruitment and sex.

Model 2 adjusted for age at recruitment, sex, education, TDI, ethnicity, family history of CRC, BMI, alcohol intake, physical activity, smoking and the first 10 genetic principal components.

Stratification analyses based on the genotypes of these four mQTLs were shown in Supplementary Tables S20–S21. A per SD increase in APES among participants with rs1870123 AA, rs497916 TC or rs11708390 CC genotypes was associated with both increased CRC risk and poorer survival, with relative risks of 1.07 (95% CI = 1.02–1.12), 1.19 (95% CI = 1.04–1.36) and 1.08 (95% CI = 1.03–1.13) for incidence and 1.34 (95% CI = 1.16–1.55), 1.04 (95% CI = 1.00–1.17) and 1.11 (95% CI = 1.00–1.24) for survival, respectively. For individuals carrying one risk allele of CRC, a per 5 μg/m3 increase in PM2.5 conferred 112% higher risk of CRC incidence among individuals with rs876961 GA genotypes.

Discussion

In this study, we comprehensively examined the associations of long-term air pollution exposure, air pollution related DNAm, and the risk and survival of CRC. We utilized an integrated approach that encompassed a prospective cohort study design, an updated meta-analysis and epigenetic MR analysis. Genetic colocalization analyses and gene–environment interaction analyses were also performed to unveil the carcinogenesis or prognosis effects of air pollution on CRC in the context of epigenetic modifications. Our findings suggest a significant association between air pollution and both the CRC incidence and survival. Notably, the methylation occurring within protein-coding genes TMBIM1/PNKD, CXCR5 and TMEM110 may partially mediate the pathogenic effects of air pollution on CRC.

We created an APES by weighted summations to evaluate joint exposure of various air pollutants and detected a robust and replicable association of APES with an elevated CRC risk as well as poorer survival, suggesting a detrimental overall effect of air pollution exposure on CRC carcinogenesis and prognosis. The subsequent meta-analysis involving data from the UK Biobank and six other multi-ancestry studies consistently support the positive association between PM2.5 exposure and increase CRC risk. However, evidence regarding other air pollutants remained relatively limited and substantial heterogeneity existed, possibly attributed to the extensive geographic diversity and ancestry variations in included studies. For overall survival in CRC survivors, we found that exposure to various air pollutants, individually or jointly as an APES, was associated with poorer CRC survival in a dose–response pattern, a phenomenon not previously investigated by epidemiological studies.30 Also, though none of the differences among stratification subgroups reached statistical significance, the adverse carcinogenic or prognostic effects of air pollution appeared to be predominantly among men, ever smokers, and those with insufficient physical activity, suggesting the potential modifying effects of lifestyle factors. In line with our findings, studies linking air pollution with diabetes mellitus,31 chronic obstructed pulmonary disease32 and cardiometabolic multimorbidity33 have consistently shown that adherence to a healthy lifestyle may mitigate the detrimental health effects of air pollution.

Previous studies have suggested that air pollution may contribute to the development of CRC via the systemic inflammatory pathway, which is linked to blood proinflammatory activity and significantly elevated mRNA and protein levels of interferon-γ and interleukin production.34 Our exploration of air pollution-induced DNAm offers a new perspective for understanding the etiological effects of air pollutants on CRC in the context of epigenetic modifications. When exploring the effects of genetically predicted air pollution-related methylation on CRC risk, cg13835894 [TMBIM1/PNKD], cg16235962 [CXCR5] and cg16947394 [TMEM110] were identified to elevate CRC risk through epigenetic modification. Moreover, our gene–environment interaction analyses revealed interaction effects with APES at mQTLs of all three aforementioned CpG sites on both CRC risk and survival, and with PM2.5 exposure at rs876961 of cg13835894 [TMBIM1/PNKD] on CRC survival.

On a population level, prolonged PM2.5 exposure has been associated with elevated C-reactive protein levels and an activated systemic inflammatory state.35 It has been proposed that PM2.5 exposure may exacerbate alterations in intestinal microbial compositions, leading to higher permeability, impaired gut barrier function, inflammatory cell infiltration, and systemic inflammation.36 The PM2.5-related CpG site cg16235962 was annotated to the gene CXCR5. This gene encodes the C-X-C motif chemokine receptor 5, which serves as the G-protein-coupled receptor of CXCL13, an important inflammatory factor in the microenvironment.37 The CXCL13-CXCR5 signaling axis is expressed mainly in both T and B cells, where it regulates lymphocyte migration and promotes inflammation.37 Consistent with the proinflammatory pathological effects of air pollutants, this axis is implicated in chronic inflammation, infectious diseases, autoimmune diseases, and tumors.37 It has been proposed to promote the growth and invasion of colon cancer cells, probably via the PI3K/AKT pathway,38 and has been reported to be associated with poor prognosis in advanced colon cancer, suggesting the potential utility of CXC family chemokines as prognostic or predictive biomarkers and possible drug targets in CRC.39

Another PM2.5-related CpG site cg16947394 is linked to TMBIM1, encoding the transmembrane BAX inhibitor motif-containing 1 protein.40 The variant rs992157, located in the intron of PNKD and TMBIM1, was found to be significantly associated with the susceptibility and progression of CRC in both European and Chinese populations, possibly via the up-regulation of TMBIM1.41,42 Similarly, disrupted PNKD function may reduce glutathione levels, increasing oxidative stress and inflammation.43 TMBIM1 has been reported to regulate Fas ligand levels, affect apoptosis and inflammation.44 Thus, PNKD and TMBIM1 may indirectly influence inflammation regulation, a key process in inflammatory bowel disease and CRC development, suggesting their potential impact on CRC via inflammation pathways. Furthermore, the mQTL rs1870123 of CpG site cg13835894 are strong eQTLs of the TMBIM1 gene in colon tissue, indicating that alterations in methylation at cg13835894 could potentially influence CRC risk through modulation of TMBIM1 gene expression. Our methylation MR and gene–environment interaction analyses offer new insights into the role of the TMBIM1 gene in CRC development from the perspectives of air pollution and DNAm.

Additionally, the transmembrane protein 110 encoded by TMEM110 was considered to regulate the long-term maintenance of endoplasmic reticulum-plasma membrane junctions and the short-term physiological remodeling of the junctions during store-dependent calcium signalling.45 A proteome profiling study of benign and malignant pulmonary nodules identified TMEM110 as a candidate biomarker for non-invasive molecular diagnosis of lung cancer due to its significant nodule-specific abundance.46 However, there was no relevant evidence of TMEM110 in the context of CRC. Our study provided evidence for its interaction with NO2, joint air pollution exposure and their pathogenic effects on CRC utilizing mQTLs, for which future functional experiment are crucial to validate our findings and to further elucidate the role of TMEM110 in CRC development.

Our findings underscored the significance of a comprehensive evaluation of multiple air pollutants and the implementation of health interventions targeting various modifiable environmental factors (e.g., air pollution, smoking, physical activity) in strengthening both primary and secondary prevention for CRC. The profound influence of epigenetic alterations on the complex pathogenesis of CRC was also emphasized. However, the underlying mechanisms by which these alterations contribute to CRC development still necessitate further exploration.

The strengths of the study include utilization of a nationally representative, well-characterized, large-scale cohort study population and an integrative approach combining a prospective cohort study, an updated meta-analysis, and an epigenetic MR analysis that enabled causal inferences linking air pollution, DNAm and CRC. The present study investigate the individual or joint effects of various air pollution on CRC risk and survival, with a particular focus on the epigenetic modification and the gene–environment interaction insights. However, some limitations need to be acknowledged. First, the CpG sites associated with air pollution were obtained from cross-sectional EWASs, thereby limited the possibility to investigate the life course or dynamic change of air pollution exposure on DNAm. Second, methylation data were derived from blood samples. Although blood DNAm is the most extensively investigated epigenetic makers,47 the methylation signature may differ across peripheral blood and specific tissues. Third, our study was unable to directly test for the mediation effects linking air pollution to CRC due to absence of individual-level DNA methylation data. Future studies with detailed methylation profiles to directly assess the potential mediating effects between air pollution and CRC are warranted. Moreover, it is imperative for further studies to incorporate individual-level methylation profiling of CpG sites, alongside gene expression data, to elucidate the intricate epigenetic mechanisms influencing gene function and carcinogenesis. Fourth, even though we adjusted for several potential confounding factors (e.g., sex, education level, family history of CRC), we lacked information on CRC stage at diagnosis, a critical determinant of survival for CRC.48 Lastly, our prospective analysis is limited to UK Biobank participants, necessitating future research with larger and more diverse populations, given the significant regional variations in outdoor air pollution in terms of both total burden and composition.11 The differential methylation patterns among ethnic subgroups warrant further investigations.49

Conclusion

In conclusion, our study provided comprehensive evidence supporting a detrimental impact of ambient air pollution on CRC risk and survival, highlighting the powerful modifying effects of epigenomic factors. The pathogenic effect of air pollution may be partly attributed to the epigenetic alterations of TMBIM1/PNKD, CXCR5, and TMEM110, where mQTL polymorphisms could modify the effects of air pollution on CRC risk and survival. This research offered new insights from epigenetic and gene–air interaction perspectives to understand the complex pathogenesis of CRC, necessitating future research with tissue-specific datasets to elucidate the underlying mechanisms.

Contributors

X.L. and E.T. conceptualized the project. F.J., W.C., and Y.Z. performed the literature review, the data analyses and wrote the first draft. J.Z. and J.S. accessed and verified the data. The manuscript was revised and edited by X.L., E.T., S.Y., S.C.L, M.G.D. and F.J., J.Z., J.S., W.C., Y.Z., S.Z., M.T., P.J.L., C.D., and R.S.H. interpreted data, reviewed the paper, and made critical revision of the manuscript for important intellectual content. X.L., E.T., and M.G.D. are the study guarantor. All authors read and approved the final version of the manuscript.

Data sharing statement

The results of this study are included in this article and the Supporting files. The UK Biobank is an open access resource and researchers required approval from the UK Biobank (www.ukbiobank.ac.uk/). Genetic data was derived from the large genome-wide association study (GWAS), Genetics of DNAm Consortium (GoDMC) and genome-wide DNAm analyses, which can be required from the published articles.

Declaration of interests

We declare no competing interests.

Acknowledgements

We appreciate the participants and managing team of UK Biobank [Application number of this study: 66354] and all investigators for sharing these data. Our work was supported by the Natural Science Fund for Distinguished Young Scholars of Zhejiang Province (LR22H260001) [XL], the National Nature Science Foundation of China (No. 82204019) [XL] and Healthy Zhejiang One Million People Cohort (K-20230085). ET is supported by a Cancer Research UK Career Development Fellowship (C31250/A22804). MGD is supported by the MRC Human Genetics Unit Centre Grant (U127527198).

Footnotes

Appendix A

Supplementary data related to this article can be found at https://doi.org/10.1016/j.ebiom.2024.105126.

Appendix A. Supplementary data

Supplementary Figures S1–S8
mmc1.docx (1.9MB, docx)
Supplementary Tables S17–S19
mmc2.xlsx (1.3MB, xlsx)

References

  • 1.Sung H., Ferlay J., Siegel R.L., et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi: 10.3322/caac.21660. [DOI] [PubMed] [Google Scholar]
  • 2.Patel S.G., Karlitz J.J., Yen T., Lieu C.H., Boland C.R. The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection. Lancet Gastroenterol Hepatol. 2022;7(3):262–274. doi: 10.1016/S2468-1253(21)00426-X. [DOI] [PubMed] [Google Scholar]
  • 3.Keum N., Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol. 2019;16(12):713–732. doi: 10.1038/s41575-019-0189-8. [DOI] [PubMed] [Google Scholar]
  • 4.Goshua A., Akdis C.A., Nadeau K.C. World Health Organization global air quality guideline recommendations: executive summary. Allergy. 2022;77(7):1955–1960. doi: 10.1111/all.15224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Liu C.W., Lee T.L., Chen Y.C., et al. PM(2.5)-induced oxidative stress increases intercellular adhesion molecule-1 expression in lung epithelial cells through the IL-6/AKT/STAT3/NF-kappaB-dependent pathway. Part Fibre Toxicol. 2018;15(1):4. doi: 10.1186/s12989-018-0240-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Schraufnagel D.E., Balmes J.R., Cowl C.T., et al. Air pollution and noncommunicable diseases: a review by the forum of international respiratory societies' environmental committee, Part 2: air pollution and organ systems. Chest. 2019;155(2):417–426. doi: 10.1016/j.chest.2018.10.041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Chu H., Xin J., Yuan Q., et al. A prospective study of the associations among fine particulate matter, genetic variants, and the risk of colorectal cancer. Environ Int. 2021;147 doi: 10.1016/j.envint.2020.106309. [DOI] [PubMed] [Google Scholar]
  • 8.Datzmann T., Markevych I., Trautmann F., Heinrich J., Schmitt J., Tesch F. Outdoor air pollution, green space, and cancer incidence in Saxony: a semi-individual cohort study. Bmc Public Health. 2018;18 doi: 10.1186/s12889-018-5615-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Turner M.C., Krewski D., Diver W.R., et al. Ambient air pollution and cancer mortality in the cancer prevention study II. Environ Health Perspect. 2017;125(8) doi: 10.1289/EHP1249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Guo C., Chan T.C., Teng Y.C., et al. Long-term exposure to ambient fine particles and gastrointestinal cancer mortality in Taiwan: a cohort study. Environ Int. 2020;138 doi: 10.1016/j.envint.2020.105640. [DOI] [PubMed] [Google Scholar]
  • 11.Pritchett N., Spangler E.C., Gray G.M., et al. Exposure to outdoor particulate matter air pollution and risk of gastrointestinal cancers in adults: a systematic review and meta-analysis of epidemiologic evidence. Environ Health Perspect. 2022;130(3) doi: 10.1289/EHP9620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Coleman N.C., Ezzati M., Marshall J.D., Robinson A.L., Burnett R.T., Pope C.A., 3rd Fine particulate matter air pollution and mortality risk among US cancer patients and survivors. JNCI Cancer Spectr. 2021;5(1) doi: 10.1093/jncics/pkab001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Coleman C.J., Yeager R.A., Riggs D.W., et al. Greenness, air pollution, and mortality risk: a U.S. cohort study of cancer patients and survivors. Environ Int. 2021;157 doi: 10.1016/j.envint.2021.106797. [DOI] [PubMed] [Google Scholar]
  • 14.de Oliveira A.A.F., de Oliveira T.F., Dias M.F., et al. Genotoxic and epigenotoxic effects in mice exposed to concentrated ambient fine particulate matter (PM(2.5)) from Sao Paulo city, Brazil. Part Fibre Toxicol. 2018;15(1):40. doi: 10.1186/s12989-018-0276-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.de F.C.L.A.J., van der Plaat D.A., de Jong K., et al. Long-term air pollution exposure, genome-wide DNA methylation and lung function in the LifeLines cohort study. Environ Health Perspect. 2018;126(2) doi: 10.1289/EHP2045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Isaevska E., Fiano V., Asta F., et al. Prenatal exposure to PM(10) and changes in DNA methylation and telomere length in cord blood. Environ Res. 2022;209 doi: 10.1016/j.envres.2022.112717. [DOI] [PubMed] [Google Scholar]
  • 17.Panni T., Mehta A.J., Schwartz J.D., et al. Genome-wide analysis of DNA methylation and fine particulate matter air pollution in three study populations: KORA F3, KORA F4, and the normative aging study. Environ Health Perspect. 2016;124(7):983–990. doi: 10.1289/ehp.1509966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Rider C.F., Carlsten C. Air pollution and DNA methylation: effects of exposure in humans. Clin Epigenet. 2019;11(1):131. doi: 10.1186/s13148-019-0713-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Vymetalkova V., Vodicka P., Vodenkova S., Alonso S., Schneider-Stock R. DNA methylation and chromatin modifiers in colorectal cancer. Mol Aspects Med. 2019;69:73–92. doi: 10.1016/j.mam.2019.04.002. [DOI] [PubMed] [Google Scholar]
  • 20.Jung G., Hernandez-Illan E., Moreira L., Balaguer F., Goel A. Epigenetics of colorectal cancer: biomarker and therapeutic potential. Nat Rev Gastroenterol Hepatol. 2020;17(2):111–130. doi: 10.1038/s41575-019-0230-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Tin A., Kottgen A. Mendelian randomization analysis as a tool to gain insights into causes of diseases: a primer. J Am Soc Nephrol. 2021;32(10):2400–2407. doi: 10.1681/ASN.2020121760. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Eeftens M., Beelen R., de Hoogh K., et al. Development of Land Use Regression models for PM(2.5), PM(2.5) absorbance, PM(10) and PM(coarse) in 20 European study areas; results of the ESCAPE project. Environ Sci Technol. 2012;46(20):11195–11205. doi: 10.1021/es301948k. [DOI] [PubMed] [Google Scholar]
  • 23.Li J., Lu A., Si S., et al. Exposure to various ambient air pollutants increases the risk of venous thromboembolism: a cohort study in UK Biobank. Sci Total Environ. 2022;845 doi: 10.1016/j.scitotenv.2022.157165. [DOI] [PubMed] [Google Scholar]
  • 24.Sudlow C., Gallacher J., Allen N., et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3) doi: 10.1371/journal.pmed.1001779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Min J.L., Hemani G., Hannon E., et al. Genomic and phenotypic insights from an atlas of genetic effects on DNA methylation. Nat Genet. 2021;53(9):1311–1321. doi: 10.1038/s41588-021-00923-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Gaunt T.R., Shihab H.A., Hemani G., et al. Systematic identification of genetic influences on methylation across the human life course. Genome Biol. 2016;17:61. doi: 10.1186/s13059-016-0926-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Li X., Timofeeva M., Spiliopoulou A., et al. Prediction of colorectal cancer risk based on profiling with common genetic variants. Int J Cancer. 2020;147(12):3431–3437. doi: 10.1002/ijc.33191. [DOI] [PubMed] [Google Scholar]
  • 28.Burgess S., Small D.S., Thompson S.G. A review of instrumental variable estimators for Mendelian randomization. Stat Methods Med Res. 2017;26(5):2333–2355. doi: 10.1177/0962280215597579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Giambartolomei C., Vukcevic D., Schadt E.E., et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 2014;10(5) doi: 10.1371/journal.pgen.1004383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Ou J.Y., Hanson H.A., Ramsay J.M., et al. Fine particulate matter air pollution and mortality among pediatric, adolescent, and Young adult cancer patients. Cancer Epidemiol Biomarkers Prev. 2020;29(10):1929–1939. doi: 10.1158/1055-9965.EPI-19-1363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Li R., Cai M., Qian Z.M., et al. Ambient air pollution, lifestyle, and genetic predisposition associated with type 2 diabetes: findings from a national prospective cohort study. Sci Total Environ. 2022;849 doi: 10.1016/j.scitotenv.2022.157838. [DOI] [PubMed] [Google Scholar]
  • 32.Wang L., Xie J., Hu Y., Tian Y. Air pollution and risk of chronic obstructed pulmonary disease: the modifying effect of genetic susceptibility and lifestyle. eBioMedicine. 2022;79 doi: 10.1016/j.ebiom.2022.103994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Chen W., Wang X., Chen J., et al. Household air pollution, adherence to a healthy lifestyle, and risk of cardiometabolic multimorbidity: results from the China health and retirement longitudinal study. Sci Total Environ. 2023;855 doi: 10.1016/j.scitotenv.2022.158896. [DOI] [PubMed] [Google Scholar]
  • 34.Ma Q.Y., Huang D.Y., Zhang H.J., Wang S., Chen X.F. Exposure to particulate matter 2.5 (PM2.5) induced macrophage-dependent inflammation, characterized by increased Th1/Th17 cytokine secretion and cytotoxicity. Int Immunopharm. 2017;50:139–145. doi: 10.1016/j.intimp.2017.06.019. [DOI] [PubMed] [Google Scholar]
  • 35.Liu Q., Gu X., Deng F., et al. Ambient particulate air pollution and circulating C-reactive protein level: a systematic review and meta-analysis. Int J Hyg Environ Health. 2019;222(5):756–764. doi: 10.1016/j.ijheh.2019.05.005. [DOI] [PubMed] [Google Scholar]
  • 36.Salim S.Y., Kaplan G.G., Madsen K.L. Air pollution effects on the gut microbiota: a link between exposure and inflammatory disease. Gut Microb. 2014;5(2):215–219. doi: 10.4161/gmic.27251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Wang B., Wang M., Ao D., Wei X. CXCL13-CXCR5 axis: regulation in inflammatory diseases and cancer. Biochim Biophys Acta Rev Cancer. 2022;1877(5) doi: 10.1016/j.bbcan.2022.188799. [DOI] [PubMed] [Google Scholar]
  • 38.Zhu Z., Zhang X., Guo H., Fu L., Pan G., Sun Y. CXCL13-CXCR5 axis promotes the growth and invasion of colon cancer cells via PI3K/AKT pathway. Mol Cell Biochem. 2015;400(1-2):287–295. doi: 10.1007/s11010-014-2285-y. [DOI] [PubMed] [Google Scholar]
  • 39.Cabrero-de Las Heras S., Martinez-Balibrea E. CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer. World J Gastroenterol. 2018;24(42):4738–4749. doi: 10.3748/wjg.v24.i42.4738. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Zhao G.N., Tian Z.W., Tian T., et al. TMBIM1 is an inhibitor of adipogenesis and its depletion promotes adipocyte hyperplasia and improves obesity-related metabolic disease. Cell Metab. 2021;33(8):1640–16454.e8. doi: 10.1016/j.cmet.2021.05.014. [DOI] [PubMed] [Google Scholar]
  • 41.Orlando G., Law P.J., Palin K., et al. Variation at 2q35 (PNKD and TMBIM1) influences colorectal cancer risk and identifies a pleiotropic effect with inflammatory bowel disease. Hum Mol Genet. 2016;25(11):2349–2359. doi: 10.1093/hmg/ddw087. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Zhang J., Fu Y., Chen J., Li Q., Guo H., Yang B. Genetic variant of TMBIM1 is associated with the susceptibility of colorectal cancer in the Chinese population. Clin Res Hepatol Gastroenterol. 2019;43(3):324–329. doi: 10.1016/j.clinre.2018.10.013. [DOI] [PubMed] [Google Scholar]
  • 43.Reuter S., Gupta S.C., Chaturvedi M.M., Aggarwal B.B. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med. 2010;49(11):1603–1616. doi: 10.1016/j.freeradbiomed.2010.09.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Rojas-Rivera D., Hetz C. TMBIM protein family: ancestral regulators of cell death. Oncogene. 2015;34(3):269–280. doi: 10.1038/onc.2014.6. [DOI] [PubMed] [Google Scholar]
  • 45.Quintana A., Rajanikanth V., Farber-Katz S., et al. TMEM110 regulates the maintenance and remodeling of mammalian ER-plasma membrane junctions competent for STIM-ORAI signaling. Proc Natl Acad Sci U S A. 2015;112(51):E7083–E7092. doi: 10.1073/pnas.1521924112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Codreanu S.G., Hoeksema M.D., Slebos R.J.C., et al. Identification of proteomic features to distinguish benign pulmonary nodules from lung adenocarcinoma. J Proteome Res. 2017;16(9):3266–3276. doi: 10.1021/acs.jproteome.7b00245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Yara S., Lavoie J.C., Levy E. Oxidative stress and DNA methylation regulation in the metabolic syndrome. Epigenomics. 2015;7(2):283–300. doi: 10.2217/epi.14.84. [DOI] [PubMed] [Google Scholar]
  • 48.Arnold M., Sierra M.S., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683–691. doi: 10.1136/gutjnl-2015-310912. [DOI] [PubMed] [Google Scholar]
  • 49.Galanter J.M., Gignoux C.R., Oh S.S., et al. Differential methylation between ethnic sub-groups reflects the effect of genetic ancestry and environmental exposures. Elife. 2017;6 doi: 10.7554/eLife.20532. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Figures S1–S8
mmc1.docx (1.9MB, docx)
Supplementary Tables S17–S19
mmc2.xlsx (1.3MB, xlsx)

Articles from eBioMedicine are provided here courtesy of Elsevier

RESOURCES